據統計空中巴士在巴黎航展錄210億美元飛機訂單 波音(BA.US)未披露新銷售
《路透》報道,據英國Cirium Ascend估計交付價格,空中巴士在今年巴黎航空展共獲148架價值142億美元的確定訂單,以及102架價值67億美元的臨時訂單,訂單總額達210億美元。競爭對手波音(BA.US)在上週印度航空787夢幻客機空難事件後選擇不公佈新銷售。
美國總統特朗普上月中東之後達成鉅額波音飛機交易,外界早已預期今年巴黎航展較爲淡靜。波音亦縮減在巴黎航展的參與,專注調查上週印度航空的墜機事件。
另一飛機製造商巴西Embraer表示,從SkyWest航空公司獲得60架E175區域噴氣機訂單,並同意購買另外50架該款飛機的優先購買權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.